Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (241-250 of 337) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pharmacology|July 20, 2016
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy SubjectsLi Zhu, Roger J Brüggemann, Jonathan Uy, et al.
The Lancet. HIV|July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2010
Drug-drug interactions between raltegravir and pravastatin in healthy volunteersMatthijs van Luin, Angela Colbers, Eleonora W J van Ewijk-Beneken Kolmer, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adultsRoeland E Wasmann, Cornelis Smit, Rob Ter Heine, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected childrenAnnemarie M van Rossum, Alina S Bergshoeff, Pieter L Fraaij, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
Pageof 34

Showing results (241-250 of 337) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pharmacology|July 20, 2016
CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy SubjectsLi Zhu, Roger J Brüggemann, Jonathan Uy, et al.
The Lancet. HIV|July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 17, 2010
Drug-drug interactions between raltegravir and pravastatin in healthy volunteersMatthijs van Luin, Angela Colbers, Eleonora W J van Ewijk-Beneken Kolmer, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
The Journal of Antimicrobial Chemotherapy|January 17, 2019
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adultsRoeland E Wasmann, Cornelis Smit, Rob Ter Heine, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected PatientsElise J Smolders, Colette Smit, Clara T M M de Kanter, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
The Pediatric Infectious Disease Journal|August 23, 2002
Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected childrenAnnemarie M van Rossum, Alina S Bergshoeff, Pieter L Fraaij, et al.
HIV Clinical Trials|January 2, 2007
No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrationsSelwyn H Lowe, Annemarie M J Wensing, Jacqueline A H Droste, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
Pageof 34